Alla Danilkovitch
2017
In 2017, Alla Danilkovitch earned a total compensation of $469.9K as Chief Scientific Officer Former Executive Officers at Osiris Therapeutics, a 86% increase compared to previous year.
Compensation breakdown
| Option Awards | $221,689 |
|---|---|
| Salary | $243,349 |
| Other | $4,855 |
| Total | $469,893 |
Danilkovitch received $243.3K in salary, accounting for 52% of the total pay in 2017.
Danilkovitch also received $221.7K in option awards and $4.9K in other compensation.
Rankings
In 2017, Alla Danilkovitch's compensation ranked 12,071st out of 14,666 executives tracked by ExecPay. In other words, Danilkovitch earned more than 17.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,071 out of 14,666 | 18th |
Division Manufacturing | 4,753 out of 5,768 | 18th |
Major group Chemicals And Allied Products | 1,733 out of 2,074 | 16th |
Industry group Drugs | 1,435 out of 1,730 | 17th |
Industry Biological Products, Except Diagnostic Substances | 261 out of 316 | 17th |
Source: SEC filing on May 11, 2018.
Danilkovitch's colleagues
We found six more compensation records of executives who worked with Alla Danilkovitch at Osiris Therapeutics in 2017.
2017
Jason Keefer
Osiris Therapeutics
Chief Executive Officer
2017
Linda Palczuk
Osiris Therapeutics
Chief Executive Officer
2017
Linda Chang
Osiris Therapeutics
Chief Financial Officer
2017
David Dresner
Osiris Therapeutics
Chief Executive Officer
2017
Gregory Law
Osiris Therapeutics
Chief Financial Officer
2017
R Avendano
Osiris Therapeutics